Top compounds associated with response to TCF25


Feature Type Standardized
Nominal ANOVA
mRNA BMS-509744 GDSC1000 pan-cancer AAC 0.058 0.3
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.041 0.3
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.035 0.3
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.043 0.3
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.04 0.3
mRNA BIX02189 GDSC1000 pan-cancer AAC 0.034 0.3
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.3
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC 0.082 0.3
Download CSV